,תכנית מדעית

Registration, Coffee and Exhibition

Congress opening- Welcome and introduction

Galit Livnat, MD; Head of the Israeli Society of CF and Head, CF Center, Carmel Medical Center, Haifa

Malena Cohen-Cymberknoh, MD; Head, CF Center, Hadassah Medical Center, Jerusalem.

“Relax I’m Vaxxed!” Vaccine coverage in CF patients

Lior Tsviban, MD; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

CF Bone disease, does the pancreas play a role?

Miri Dotan, MD; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

Does Trikafta influence incontinence in Cystic Fibrosis?

Tomer Israeli, B.P.T; CF Center and Department of Physiotherapy, Hadassah Medical Center, Jerusalem

"Doctor, I needed a gastrostomy and now I need a diet!" – The effect of Trikafta on bone mineral density, body composition and exercise capacity

Michal Gur, MD; CF Center, Ruth Rapaport Children's Hospital, Rambam Health Care Center, Haifa

Aquagenic wrinkling of the palms

Eyal Jacobi, MD; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

Infant spirometry as a predictor of lung function at early childhood in CF patients

Mordechai Pollak, MD, MSc, Paediatric Respiratory Medicine at The Hospital for Sick Children, Toronto, Canada;  CF Center, Ruth Rapaport Children's Hospital, Rambam Health Care Center, Haifa

Measuring KCO in patients with CF - a big headache

Daphna Vilozni, PhD; Pediatric Pulmonary Unit, CF Center, The Edmond and Lily Safra Children's Hospital, Sheba Medical

Lunch- CF Professional Group Meetings:

• Physicians
• Nurses and Research Coordinators
• Dieticians
• Physiotherapists 
• Pharmacists
• Psychologists and Social workers

Session B: "CF in the new era: Are we close to the end of the tunnel?"

Chairs: Liron Birimberg Schwartz, MD and Karin Yaacobi-Bianu, MD

New developments and future outlook

Fredrick Van Goor, PhD; Head of Cystic Fibrosis Research, Vertex Pharmaceutical, USA

Allosteric control of the CFTR protein

Oded Lewinson, PhD, Faculty of Medicine, The Technion-Israel Institute of Technology, Haifa

SPL84 and SPL23 for the treatment of CF patients - from the bench to patient bedside

Gili Hart, MD; Splisense- CEO

CF research in patient-derived organoids: personalized medicine and drug development Noemi Stanleigh, PhD; the Genetic Department, the Silberman Institute of Life Science, the Hebrew University of Jerusalem

Individualized therapy in CF (focusing on patient derived epithelial cells and genetic markers of treatment response)

Felix Ratjen, MD; Division Chief of Paediatric Respiratory Medicine at The Hospital for Sick Children, Toronto, Canada

Coffee Break and Exhibition

Session C: “Trikafta treatment, for all?”

Chairs: Michal Shteinberg, MD, PhD and Dario Prais, MD

Differences in disease severity among different Residual Function Mutations: Data from the ECFS Patient Registry

Meir Mei-Zahav, MD; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

The impact of ETI on "milder" CF patients - The Israeli experience

Galit Livnat, MD; CF Center, Carmel Medical Center, Haifa

Clinical response to Elexacaftor/Tezacaftor/Ivacaftor in patients with Cystic fibrosis carrying N1303K and non-modulator responsive mutation

Ido Sadras, MD; CF Center, Hadassah Medical Center, Jerusalem

The nuts and bolts of the Trikafta era

Eddie Landau, Clinical and Medical Psychologist, MSc, PhD and Dana Serfaty. BSc, MPH; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

A "heavy" decision – should we start Trikafta in a patient recovering from fulminant hepatic failure?

Michal Gur, MD; CF Center, Ruth Rapaport Children's Hospital, Rambam Health Care Center, Haifa

Almost or not quite CF-To Treat with modulators?

Michael Wilschansky, MD; CF Center, Hadassah Medical Center, Jerusalem

The future challenges of CF in the post CFTR modulators era

Eitan Kerem, MD; CF Center, Hadassah Medical Center, Jerusalem

Breakfast

Session D: "Airway infection and pulmonary exacerbations in CF"

Chairs: Shlomit Keler, MD and Inbal Golan-Tripto, MD

Acute respiratory events in CF (focusing on diagnosis, treatment and long-term impact of milder events)

Felix Ratjen, MD; Division Chief of Paediatric Respiratory Medicine at The Hospital for Sick Children, Toronto, Canada

Dual inhaled antibiotics to treat exacerbations

Moshe Heching, MD; CF Center, Beilinson Medical Center, Petah Tikva

To draw the IV fear away

Hagit Levine, MD and Diana Kadosh, MSW; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

Success vs. failure to eradicate Nontuberculous Mycobacterium in Cystic Fibrosis patients treated with Trikafta (Elexacaftor/Tezacaftor/Ivacaftor): A Multicenter Cohort Study

Vered Wiesel- Medical Student from MSIH (Medical School for International Health)- Ben Gurion University of the Negev

Can CMV cause respiratory deterioration in cystic fibrosis? Case presentation

Argyri Petrocheilou, MD, MSc. Pediatric Pulmonologist. Attending Cystic Fibrosis Department. Agia Sofia Children’s Hospital, Athens Greece

The impact of Methicillin-Resistant Staphylococcus Aureus on pulmonary outcome across Europe – Data from the ECFS Patient Registry

Dario Prais, MD; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

Coffee Break and Exhibition

Session F: "Pearls in CF- General issues”

 Chairs: Hagit Levin, MD and Malena Cohen-Cymberknoh, MD

Male sexual and reproductive health in the era of HEMT

Jennifer L. Taylor-Cousar, MD, MSCS, ATSF; Divisions of Pulmonary Sciences and Critical Care Medicine and Pediatric Pulmonology; Co-Director and CF TDC Director, Adult CF Center, National Jewish Health, USA

Ovarian reserve in women with Cystic fibrosis: is this a cause of subfertility?

Anat Hershko Klement, MD; The IVF Unit, Mount Scopus, Hadassah Medical Center, Jerusalem

The exocrine pancreas in the era of CFTR modulation

Liron Birimberg Schwartz, MD; CF Center, Hadassah Medical Center, Jerusalem

ECFS patient’s registry report

Meir Mei-Zahav, MD; Graub CF Center, Schneider Children's Medical Center, Petah Tikva

The Future of Gene Therapy in CF

Jennifer L. Taylor-Cousar, MD, MSCS, ATSF; Divisions of Pulmonary Sciences and Critical Care Medicine and Pediatric Pulmonology; Co-Director and CF TDC Director, Adult CF Center, National Jewish Health, USA

Closing remarks

Malena Cohen-Cymberknoh, MD; Head, CF Center, Hadassah Medical Center, Jerusalem

Galit Livnat, MD; Head of the Israeli Society of CF and Head, CF Center, Carmel Medical Center, Haifa

Lunch